Development of an epigenetic clock resistant to changes in immune cell composition

A Tomusiak, A Floro, R Tiwari, R Riley… - Communications …, 2024 - nature.com
Epigenetic clocks are age predictors that use machine-learning models trained on DNA CpG
methylation values to predict chronological or biological age. Increases in predicted …

Targeting nuclear hormone receptors for the prevention of breast cancer

CL Moyer, PH Brown - Frontiers in Medicine, 2023 - frontiersin.org
Advancements in research have led to the steady decline of breast cancer mortality over the
past thirty years. However, breast cancer incidence has continued to rise, resulting in an …

Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses

A López-Cortés, A Cabrera-Andrade… - Scientific Reports, 2024 - nature.com
The druggable proteome refers to proteins that can bind to small molecules with appropriate
chemical affinity, inducing a favorable clinical response. Predicting druggable proteins …

Development of a novel epigenetic clock resistant to changes in immune cell composition

A Tomusiak, A Floro, R Tiwari, R Riley, H Matsui… - bioRxiv, 2023 - biorxiv.org
Epigenetic clocks are age predictors that use machine-learning models trained on DNA CpG
methylation values to predict chronological or biological age. Increases in predicted …

Genomes and epigenomes of matched normal and tumor breast tissue reveal diverse evolutionary trajectories and tumor-host interactions

B Zhu, A Tapinos, H Koka, PMY Lee, T Zhang… - The American Journal of …, 2024 - cell.com
Normal tissues adjacent to the tumor (NATs) may harbor early breast carcinogenesis events
driven by field cancerization. Although previous studies have characterized copy-number …

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment

C Herzog, A Jones, I Evans, M Zikan, D Cibula… - NPJ Precision …, 2023 - nature.com
To individualise breast cancer (BC) prevention, markers to follow a person's changing
environment and health extending beyond static genetic risk scores are required. Here, we …

Breast Cancer Risk Reduction: Current Status and Emerging Trends to Increase Efficacy and Reduce Toxicity of Preventive Medication

SA Khan - Surgical Oncology Clinics, 2023 - surgonc.theclinics.com
Although “chemoprevention” is a revered term. it is time for the word to be retired from the
clinic for it conveys the wrong message, that of toxic chemotherapy. The terminology needs …

Impact of breast cancer and germline BRCA pathogenic variants on fertility preservation in young women

E Prokurotaite, M Condorelli, J Dechene, J Bouziotis… - Life, 2023 - mdpi.com
Background: Several studies have suggested that breast cancer (BC) and germline BRCA
pathogenic variants (gBRCA PVs) could have a deleterious impact on ovarian reserve …

Antiprogestins for breast cancer treatment: We are almost ready

A Elia, G Pataccini, L Saldain, L Ambrosio… - The Journal of Steroid …, 2024 - Elsevier
The development of antiprogestins was initially a gynecological purpose. However, since
mifepristone was developed, its application for breast cancer treatment was immediately …

[HTML][HTML] Secondary Transcriptomic Analysis of Triple-Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific Mechanistic Markers

N Rapier-Sharman, MD Spendlove, JB Poulsen… - Cancers, 2024 - mdpi.com
Simple Summary Breast cancer is diagnosed in 2.3 million women each year and kills
685,000 (~ 30% of patients) worldwide. The most dangerous breast cancer is triple-negative …